257 related articles for article (PubMed ID: 29558726)
1. Detection of salivary protein biomarkers of saliva secretion disorder in a primary Sjögren syndrome murine model.
Liang P; Zhu W; Lan T; Tao Q
J Pharm Biomed Anal; 2018 May; 154():252-262. PubMed ID: 29558726
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
4. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
5. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
7. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
8. Thymosin β
Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
[TBL] [Abstract][Full Text] [Related]
9. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
[TBL] [Abstract][Full Text] [Related]
10. The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome.
Weng X; Liu Y; Cui S; Cheng B
Arthritis Res Ther; 2018 Sep; 20(1):205. PubMed ID: 30189901
[TBL] [Abstract][Full Text] [Related]
11. Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals Potential Salivary Biomarkers of Primary Sjögren's Syndrome.
Tian YC; Guo CL; Li Z; You X; Liu XY; Su JM; Zhao SJ; Mu Y; Sun W; Li Q
Chin Med Sci J; 2024 Mar; 39(1):19-28. PubMed ID: 38623048
[TBL] [Abstract][Full Text] [Related]
12. Proteomic diagnosis of Sjögren's syndrome.
Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
[TBL] [Abstract][Full Text] [Related]
13. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations.
Delaleu N; Immervoll H; Cornelius J; Jonsson R
Arthritis Res Ther; 2008; 10(1):R22. PubMed ID: 18289371
[TBL] [Abstract][Full Text] [Related]
14. Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review.
Jung JY; Kim JW; Kim HA; Suh CH
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884709
[TBL] [Abstract][Full Text] [Related]
15. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.
Delaleu N; Mydel P; Kwee I; Brun JG; Jonsson MV; Jonsson R
Arthritis Rheumatol; 2015 Apr; 67(4):1084-95. PubMed ID: 25545990
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.
Robinson CP; Yamachika S; Alford CE; Cooper C; Pichardo EL; Shah N; Peck AB; Humphreys-Beher MG
Proc Natl Acad Sci U S A; 1997 May; 94(11):5767-71. PubMed ID: 9159148
[TBL] [Abstract][Full Text] [Related]
17. Salivary lipids in health and disease.
Slomiany BL; Murty VL; Slomiany A
Prog Lipid Res; 1985; 24(4):311-24. PubMed ID: 3916593
[No Abstract] [Full Text] [Related]
18. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
19. Salivary β2-microglobulin positively correlates with ESSPRI in patients with primary Sjögren's syndrome.
Garza-García F; Delgado-García G; Garza-Elizondo M; Ceceñas-Falcón LÁ; Galarza-Delgado D; Riega-Torres J
Rev Bras Reumatol Engl Ed; 2017; 57(2):182-184. PubMed ID: 28343624
[No Abstract] [Full Text] [Related]
20. Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice.
Delaleu N; Jonsson R
Arthritis Res Ther; 2008; 10(4):114. PubMed ID: 18710591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
